Nuklearmedizin - NuclearMedicine

---

• Wissenschaftliche Poster

• Leuchtfeuer

P100

Nikulin, P; Hofheinz, F; Maus, J; Pietsch, J; Li, Y; Bütof, R; Lange, C; Furth, C; Kreißl, MC; Kotzerke, J; van den Hoff, J:

A convolutional neural network for fully automated blood SUV determination in oncological FDG-PET

•      
• Abstract

P101

Beyer, L; Nitschmann, A; Barthel, H; van Eimeren, T; Unterrainer, M; Sauerbeck, J; Song, M; Schroeter, ML; Russell, DS; Stephens, A; Herms, J; Levin, J; Classen, J; Höglinger, G; Bartenstein, P; Villemagne, V; Drzezga, A; Seibyl, J; Sabri, O; Brendel, M:

Perfusion-Phase ¹⁸F-PI-2620 Tau-PET Imaging as a Surrogate Marker of Neuronal Injury

•      
• Abstract

P102

Seifert, P; Winkens, T; Kühnel, C; Gühne, F; Freesmeyer, M:

99m-technetium-SPECT/US and I-124-PET/US fusion imaging in comparison to conventional diagnostics for the functional assessment of thyroid nodules

•      
• Abstract

P103

Sadeghzadeh, M; Wenzel, B; Gündel, D; Deuther-Conrad, W; Toussaint, M; Moldovan, RP; Teodoro, R; Jonnalagadda, S; Jonnalagadda, SK; Mereddy, VR; Drewes, LR; Brust, P:

Novel 2-fluoropyridinyl analogs of FACH and biological evaluation of one potential radioligand for imaging of monocarboxylate transporters (MCTs) with PET

•      
• Abstract

P104

Langbein, T; Wurzer, A; Krönke, M; Herz, M; Wörther, H; Franz, C; Weber, WA; Wester, HJ; Eiber, M:

Does the Injected Mass influence the Biodistribution of F-18-rhPSMA-7.3 on Positron Emission Tomography in Prostate Cancer Patients?

•      
• Abstract

P105

Sörensen, A; Blazhenets, G; Schiller, F; Meyer, PT; Frings, L:

Amyloid-Marker zur Prädiktion der Konversion von MCI zur Alzheimer-Demenz: Vergleich verschiedener Verfahren

•      
• Abstract

P106

Zimmer, NM; Raue, F; Pfestroff, A; Luster, M:

Radioligandentherapie mittels Indium-111-Minigastrin bei metastasiertem medullären Schilddrüsenkarzinom (MTC)

•      
• Abstract

P107

Körber, S; Staudinger, F; Kratochwil, C; Ristau, J; Haefner, MF; Adeberg, S; Rathke, H; Winter, E; Lindner, T; Herfarth, K; Debus, J; Haberkorn, U; Giesel, FL:

Einsatz von FAPI-PET/CT im (radio-)onkologischen Alltag – erste klinische Erfahrungen bei Patienten mit gastrointestinalen Tumoren

•      
• Abstract

P108

Lohmann, P; Elahmadawy, MA; Kocher, M; Werner, JM; Rapp, M; Ceccon, G; Fink, GR; Shah, NJ; Langen, KJ; Galldiks, N:

FET PET radiomics for the diagnosis of pseudoprogression in patients with glioblastoma

•      
• Abstract

P109

Iking, J; Hermann, S; Honold, L; Kuhlmann, M; Schäfers, M; Waltenberger, J; Stegger, L; Pardali, E:

In vivo imaging of human monocyte localization in the early and late inflammatory phase of mouse myocardial infarction

•      
• Abstract

P110

Kertels, O; Breun, M; Hänscheid, H; Kircher, M; Hartrampf, P; Schirbel, A; Monoranu, CM; Ernestus, RI; Buck, AK; Löhr, M; Matthies, C; Lapa, C:

Peptide Receptor Radionuclide Therapy in Patients with Neurofibromatosis Type 2 – Initial Experience

•      
• Abstract

P111

Albers, J; Senger, C; Kluge, A; Lukas, M; Acker, G; Baur, A; Huang, K; Thiele, F; Schatka, I; Amthauer, H; Furth, C:

Einfluss der Uptake-Zeit in der Ga68-DOTATOC PET/MRT auf das Planungszielvolumen von Meningeomen vor stereotaktischer Strahlentherapie

•      
• Abstract